West Chester, OH, United States of America

Charles A Cruze, Iii

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Bexion Pharmaceuticals Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles A Cruze, Iii. Retrieved from https://idiyas.com/inventor/charles-a-cruze-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charles A Cruze, III

Introduction

Charles A Cruze, III is a notable inventor based in West Chester, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 2 patents, his work has the potential to impact the lives of many patients.

Latest Patents

Cruze's latest patents include innovative pharmaceutical compositions that utilize saposin C and phosphatidylserine. These compositions are designed to treat various types of cancers, showcasing his commitment to advancing medical science. The details of these patents highlight the importance of saposin C in developing effective cancer therapies.

Career Highlights

Throughout his career, Charles A Cruze, III has been associated with Bexion Pharmaceuticals Inc., where he has played a crucial role in research and development. His expertise in pharmaceutical compositions has positioned him as a key figure in the fight against cancer.

Collaborations

Some of his notable coworkers include Ellen K Monson and Xiaochen Wei, who have collaborated with him on various projects. Their combined efforts contribute to the innovative environment at Bexion Pharmaceuticals Inc.

Conclusion

Charles A Cruze, III exemplifies the spirit of innovation in the pharmaceutical industry. His work in developing treatments for cancer through saposin C compositions is a testament to his dedication and expertise.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…